In ACS with multivessel CAD, immediate vs. staged complete revascularization was noninferior for a composite outcome at 1 y

Manoj Kesarwani

doi:10.7326/J23-0049

In ACS with multivessel CAD, immediate vs. staged complete revascularization was noninferior for a composite outcome at 1 y

Ann Intern Med. 2023 Jul;176(7):JC76. doi: 10.7326/J23-0049. Epub 2023 Jul 4.

Author

Manoj Kesarwani¹

Affiliation

¹ University of California, Davis School of Medicine, Sacramento, California, USA (M.K.).

PMID: 37399558
DOI: 10.7326/J23-0049

Abstract

Diletti R, den Dekker WK, Bennett J, et al; BIOVASC Investigators. Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial. Lancet. 2023;401:1172-1182. 36889333.

Publication types

Randomized Controlled Trial
Comment

MeSH terms

Acute Coronary Syndrome* / surgery
Coronary Artery Disease* / surgery
Humans
Percutaneous Coronary Intervention*
Prospective Studies
Treatment Outcome
Vascular Surgical Procedures